Abbott Laboratories (ABT)
115.90
+0.87
(+0.76%)
USD |
NYSE |
Nov 15, 16:00
116.37
+0.47
(+0.41%)
After-Hours: 20:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 201.02B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| All-Time High (Daily) | Upgrade |
| Year to Date Total Returns (Daily) | Upgrade |
| 1 Month Total Returns (Daily) | Upgrade |
| 1 Year Total Returns (Daily) | 20.64% |
| Valuation | |
| PE Ratio | 35.23 |
| PE Ratio (Forward) | Upgrade |
| PS Ratio | 4.917 |
| Price to Book Value | 5.051 |
| EV to EBITDA | Upgrade |
| Dividend | |
|---|---|
| Dividend | 0.55 |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | 0.3764 |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | 33.88% |
Profile
| Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States. |
| URL | https://www.abbottinvestor.com |
| Investor Relations URL | https://www.abbott.com/investors.html |
| HQ State/Province | Illinois |
| Sector | Health Care |
| Industry | Health Care Equipment & Supplies |
| Equity Style | Large Cap/Value |
| Next Earnings Release | Jan. 24, 2025 (est.) |
| Last Earnings Release | Oct. 16, 2024 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Oct. 15, 2024 |
Ratings
Profile
| Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States. |
| URL | https://www.abbottinvestor.com |
| Investor Relations URL | https://www.abbott.com/investors.html |
| HQ State/Province | Illinois |
| Sector | Health Care |
| Industry | Health Care Equipment & Supplies |
| Equity Style | Large Cap/Value |
| Next Earnings Release | Jan. 24, 2025 (est.) |
| Last Earnings Release | Oct. 16, 2024 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Oct. 15, 2024 |